Mirabegron or tolterodine for the treatment of overactive bladder in Japan: Which drug is more cost ‐effective as the first‐line treatment?

International Journal of Urology, EarlyView.

Source: International Journal of Urology - August 16, 2018 Category: Urology & Nephrology Authors: Yuriko Yamanishi , Tomonori Yamanishi , Hakujyu Tajima , Shunya Ikeda Source Type: research